Beyond GLP-1: Charting the Future of Peptide Therapeutics in Metabolic Disease : Short title: Beyond GLP-1 Peptide Therapeutics. [PDF]
Pezeshki B, Farjam M, Karimi A.
europepmc +1 more source
Peripheral amylin modulation rebalances brain glycolysis and Tau-Ser214 phosphorylation via cAMP-PKA signaling. [PDF]
Davargaon RS +14 more
europepmc +1 more source
Recent developments in GPCR signalling in appetite regulation. [PDF]
Brittain HR, Gorvin CM.
europepmc +1 more source
Amylin Receptor: A Common Pathophysiological Target in Alzheimer’s Disease and Diabetes Mellitus [PDF]
Amylin (islet amyloid polypeptide) and amyloid beta protein (Abeta), which are deposited within pancreatic islets of diabetics and brains of Alzheimer’s patients respectively, share many biophysical and physiological properties.
Jack H Jhamandas, Aarti Patel, Wen Fu
exaly +4 more sources
Molecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin [PDF]
The pancreatic peptide hormone, amylin, plays a critical role in the control of appetite, and synergizes with other key metabolic hormones such as glucagon-like peptide 1 (GLP-1).
Christopher Walker +2 more
exaly +6 more sources
Pharmacological Characterization of Rat Amylin Receptors: Implications for the Identification of Amylin Receptor Subtypes [PDF]
BACKGROUND AND PURPOSEAmylin (Amy) is an important glucoregulatory peptide and AMY receptors are clinical targets for diabetes and obesity. Human (h) AMY receptor subtypes are complexes of the calcitonin (CT) receptor with receptor activity‐modifying proteins (RAMPs); their rodent counterparts have not been characterized. To allow identification of the
Christopher Walker +2 more
exaly +4 more sources
Background: Therapies for metabolic diseases are numerous, yet improving insulin sensitivity beyond that induced by weight loss remains challenging. Therefore, search continues for novel treatment candidates that can stimulate insulin sensitivity and ...
Morten Karsdal +2 more
exaly +3 more sources
Related searches:
A structural basis for amylin receptor phenotype
Science, 2022Amylin receptors (AMYRs) are heterodimers of the calcitonin (CT) receptor (CTR) and one of three receptor activity–modifying proteins (RAMPs), AMY 1 R, AMY 2 R, and AMY 3 R.
Jianjun Cao +10 more
openaire +2 more sources
Amylin and the Amylin Receptors in Migraine: Is There Another Pathway to Target?
Here, we review the available evidence implicating amylin in migraine, its relationship with calcitonin gene-related peptide (CGRP) and its potential utility as a therapeutic target. The pathophysiology of migraine is currently better understood and the role of CGRP is key.
David Moreno-Ajona +2 more
exaly +3 more sources
Amylin receptors: molecular composition and pharmacology
Biochemical Society Transactions, 2004Several receptors which bind the hormone AMY (amylin) with high affinity have now been identified. The minimum binding unit is composed of the CT (calcitonin) receptor at its core, plus a RAMP (receptor activity modifying protein). The receptors have been named AMY1(a), AMY2(a) and AMY3(a) in accordance with the association of the CT receptor (CT(a ...
D L, Hay +3 more
openaire +2 more sources

